New research suggests certain antiplatelet medications may worsen outcomes after brain bleeds, prompting clinicians to reassess prescribing decisions and emergency management strategies.

Rising numbers of elderly Americans with mitral regurgitation are driving personalized treatment strategies, balancing surgery and minimally invasive options to improve outcomes and quality of life.

New Alzheimer’s research identifies molecularly distinct patient subgroups, paving the way for personalized treatments tailored to biological profiles, lifestyles, and individual care needs.

Biological aging metrics may transform steatotic liver disease care, enabling better risk assessment, earlier interventions, and more personalized treatment strategies beyond chronological age alone.

New insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, prompting personalized discussions about timing, benefits, and safer menopause management.

A recent study suggests the plant-based EAT-Lancet diet may lower chronic kidney disease risk, linking healthier eating patterns with improved kidney outcomes and environmental sustainability benefits.

Growing emphasis on clear researcher-public communication underscores need for accessible health information, building trust, countering misinformation, and empowering patients to make informed treatment decisions.

Rising antibiotic resistance in Streptococcus pneumoniae highlights urgent need to understand its protective capsule, guiding innovative vaccines, improved treatments, and strategies to preserve antibiotic effectiveness.

New research reveals Type 2 diabetes involves genetic activity across multiple tissues, advancing understanding of disease mechanisms and supporting more personalized, inclusive prevention and treatment strategies.